- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anterogen Co Ltd (065660)
Track today's live Anterogen (065660) share price, performance and key data on this page with our current KOSDAQ:065660 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Anterogen share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 065660 share price, head to our technical summary section, which provides analysis on Anterogen share price buy/sell indicators using real-time data (or discuss the Anterogen (065660) stock price today with other investors in the Anterogen KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:065660 share price (ISIN: KR7065660003) to enhance your trading decisions with our free investment tools and resources.
What Is the Anterogen Co Ltd Share Price Today?
The Anterogen share price today is 15,140.
What Is the Stock Symbol for Anterogen Co Ltd
The stock symbol (or 'ticker') for Anterogen Co Ltd is "065660."
What Stock Exchange Does Anterogen Co Ltd Trade On?
Anterogen Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Anterogen Co Ltd a Good Stock to Buy?
Determining whether Anterogen (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:065660 share price (ISIN: KR7065660003) to enhance your trading decisions with our free investment tools and resources.
What Is the Anterogen Co Ltd Share Price Today?
The Anterogen share price today is 15,140.
What Is the Stock Symbol for Anterogen Co Ltd
The stock symbol (or 'ticker') for Anterogen Co Ltd is "065660."
What Stock Exchange Does Anterogen Co Ltd Trade On?
Anterogen Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Anterogen Co Ltd a Good Stock to Buy?
Determining whether Anterogen (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
15,140
-530(-3.38%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,230
15,680
52 wk Range
13,500
61,800
065660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,23015,680
52 wk Range
13,50061,800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
065660 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
15/05/2026
EPS / Forecast
-88.00 / --
Revenue / Forecast
2.12B / --
Compare 065660 to Peers and Sector
Metrics to compare | 065660 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship065660PeersSector | |
|---|---|---|---|---|
P/E Ratio | −97.3x | −9.5x | −0.3x | |
PEG Ratio | - | −0.19 | 0.00 | |
Price/Book | 1.8x | 2.2x | 2.6x | |
Price / LTM Sales | 18.8x | 7.9x | 3.1x | |
Upside (Analyst Target) | - | 66.5% | 47.6% | |
Fair Value Upside | Unlock | 17.4% | 5.6% | Unlock |
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn’s fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as stem cell media program set, a cosmetic raw material. In addition, the company offers stem cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Anterogen (KOSDAQ: 065660) Share Price Today?
The Anterogen stock price today is 15,140 KRW.
What Stock Exchange Does Anterogen (065660) Trade On?
Anterogen is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for Anterogen?
The stock symbol (also called a 'ticker') for Anterogen is "065660."
What Is the Current Anterogen Market Capitalisation?
As of today, Anterogen (KOSDAQ: 065660) market cap is 151.49B KRW.
What Is Anterogen's (065660) Earnings Per Share (TTM)?
The Anterogen EPS is currently -155 (Trailing Twelve Months).
Is 065660 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Anterogen moving averages and other technical indicators, the daily buy/sell signal for 065660 stock is Strong Sell.
How Many Times Has Anterogen Stock Split?
Anterogen has split 0 times. (See the 065660 stock split history page for full effective split date and price information.)
What is the current trading status of Anterogen (KOSDAQ: 065660)?
As of 22/08/2026, Anterogen (065660) is trading at a share price of 15,140 KRW, with a previous close of 15,670 KRW. The stock has fluctuated within a day range of 14,230 KRW to 15,680 KRW, while its 52-week range spans from 13,500 KRW to 61,800 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.